Symbols / ZYBT Stock $0.92 -0.02% Zhengye Biotechnology Holding Limited

Healthcare • Drug Manufacturers - Specialty & Generic • China • NCM
ZYBT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Songlin Song
Exch · Country NCM · China
Market Cap 43.60M
Enterprise Value 147.90M
Income -19.37M
Sales 153.74M
FCF (ttm) 24.23M
Book/sh 0.91
Cash/sh 1.00
Employees 277
Insider 10d —
IPO Jan 07, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 0.28
P/B 1.01
P/C —
EV/EBITDA -66.83
EV/Sales 0.96
Quick Ratio 1.00
Current Ratio 1.49
Debt/Eq 23.49
LT Debt/Eq —
EPS (ttm) -0.06
EPS next Y —
EPS Growth —
Revenue Growth -34.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -3.45%
ROE -6.38%
ROIC —
Gross Margin 37.37%
Oper. Margin -46.33%
Profit Margin -12.60%
Shs Outstand 47.39M
Shs Float 4.42M
Insider Own 5.85%
Instit Own 3.12%
Short Float 1.15%
Short Ratio 0.09
Short Interest 51.12K
52W High 14.30
vs 52W High -93.57%
52W Low 0.68
vs 52W Low 35.28%
Beta —
Impl. Vol. —
Rel Volume 0.03
Avg Volume 216.40K
Volume 7.36K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.92
Price $0.92
Change -0.02%
About

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.92
Latest analyst target
3. DCF / Fair value
$9.20
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.92
Low
—
High
—
Mean
—
News
RSS: Latest ZYBT news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
186.36
-11.95%
211.65
-18.68%
260.27
+21.58%
214.07
Operating Revenue
173.29
-15.20%
204.35
-18.90%
251.98
+17.71%
214.07
Cost Of Revenue
95.06
+0.98%
94.14
-16.24%
112.39
+26.75%
88.67
Reconciled Cost Of Revenue
95.06
+0.98%
94.14
-16.24%
112.39
+26.75%
88.67
Gross Profit
91.30
-22.31%
117.51
-20.54%
147.88
+17.93%
125.39
Operating Expense
74.12
+6.09%
69.87
-14.58%
81.79
+17.20%
69.79
Research And Development
12.79
+7.50%
11.90
-11.35%
13.42
+18.07%
11.37
Selling General And Administration
63.84
-0.76%
64.33
+9.25%
58.89
+1.19%
58.19
Selling And Marketing Expense
41.27
+1.29%
40.74
+17.87%
34.56
-3.73%
35.90
General And Administrative Expense
22.57
-4.31%
23.59
-3.00%
24.32
+9.11%
22.29
Other Gand A
22.57
-4.31%
23.59
-3.00%
24.32
+9.11%
22.29
Other Operating Expenses
-0.73
+72.37%
-2.65
-940.39%
-0.26
+85.01%
-1.70
Total Expenses
169.18
+3.15%
164.01
-15.54%
194.18
+22.54%
158.46
Operating Income
17.17
-63.95%
47.64
-27.92%
66.09
+18.85%
55.60
Total Operating Income As Reported
16.44
-63.46%
44.99
-31.67%
65.83
+25.68%
52.38
EBITDA
42.60
-40.91%
72.10
-15.73%
85.55
+22.00%
70.12
Normalized EBITDA
41.92
-41.85%
72.10
-15.73%
85.55
+19.41%
71.64
Reconciled Depreciation
24.16
+1.05%
23.91
+27.19%
18.80
+17.41%
16.01
EBIT
18.44
-61.74%
48.19
-27.82%
66.75
+23.36%
54.11
Total Unusual Items
0.68
+106.76%
-10.05
-938.02%
-0.97
+36.36%
-1.52
Total Unusual Items Excluding Goodwill
0.68
+106.76%
-10.05
-938.02%
-0.97
+36.36%
-1.52
Special Income Charges
—
-10.05
-938.02%
-0.97
+36.36%
-1.52
Write Off
—
10.05
+938.02%
0.97
-36.36%
1.52
Net Income
11.31
-64.04%
31.46
-32.69%
46.73
+19.96%
38.96
Pretax Income
14.39
-67.11%
43.76
-31.53%
63.91
+20.44%
53.07
Net Non Operating Interest Income Expense
-3.81
+7.27%
-4.11
-50.86%
-2.73
-191.76%
-0.93
Interest Expense Non Operating
4.04
-8.59%
4.42
+55.79%
2.84
+171.41%
1.05
Net Interest Income
-3.81
+7.27%
-4.11
-50.86%
-2.73
-191.76%
-0.93
Interest Expense
4.04
-8.59%
4.42
+55.79%
2.84
+171.41%
1.05
Interest Income Non Operating
0.23
-25.96%
0.31
+173.68%
0.11
+1.79%
0.11
Interest Income
0.23
-25.96%
0.31
+173.68%
0.11
+1.79%
0.11
Other Income Expense
1.03
+341.88%
0.23
-57.45%
0.55
+134.27%
-1.60
Other Non Operating Income Expenses
0.35
+51.71%
0.23
-57.45%
0.55
+754.76%
-0.08
Gain On Sale Of Security
0.68
—
—
—
Tax Provision
0.92
-85.22%
6.25
-23.48%
8.17
+23.84%
6.60
Tax Rate For Calcs
0.00
-55.24%
0.00
+11.72%
0.00
+2.93%
0.00
Tax Effect Of Unusual Items
0.04
0.00
0.00
+100.00%
-0.19
Net Income Including Noncontrolling Interests
13.47
-64.09%
37.51
-32.71%
55.74
+19.96%
46.47
Net Income From Continuing Operation Net Minority Interest
11.31
-64.04%
31.46
-32.69%
46.73
+19.96%
38.96
Net Income From Continuing And Discontinued Operation
11.31
-64.04%
31.46
-32.69%
46.73
+19.96%
38.96
Net Income Continuous Operations
13.47
-64.09%
37.51
-32.71%
55.74
+19.96%
46.47
Minority Interests
-2.16
+64.33%
-6.05
+32.81%
-9.01
-19.97%
-7.51
Normalized Income
10.68
-66.06%
31.46
-32.69%
46.73
+15.99%
40.29
Net Income Common Stockholders
11.31
-64.04%
31.46
-32.69%
46.73
+19.96%
38.96
Diluted EPS
0.24
-64.04%
0.67
-32.69%
0.99
+19.96%
0.83
Basic EPS
0.24
-65.19%
0.69
-32.69%
1.02
+19.96%
0.85
Basic Average Shares
47.17
+3.28%
45.67
+0.00%
45.67
+0.00%
45.67
Diluted Average Shares
47.17
+0.00%
47.17
+0.00%
47.17
+0.00%
47.17
Diluted NI Availto Com Stockholders
11.31
-64.04%
31.46
-32.69%
46.73
+19.96%
38.96
Provision For Doubtful Accounts
-1.78
+52.02%
-3.71
-138.15%
9.73
+405.71%
1.93
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
493.25
-1.33%
499.89
-3.81%
519.67
+16.71%
445.28
Current Assets
177.57
-6.17%
189.24
-11.70%
214.31
+29.93%
164.94
Cash Cash Equivalents And Short Term Investments
20.04
+22.95%
16.30
+67.22%
9.75
+55.09%
6.28
Cash And Cash Equivalents
18.60
+23.43%
15.07
+54.66%
9.75
+55.09%
6.28
Cash Financial
18.60
+23.43%
15.07
+54.66%
9.75
+55.09%
6.28
Other Short Term Investments
1.43
+17.08%
1.22
0.00
—
Receivables
88.52
-10.97%
99.42
-25.94%
134.25
+31.38%
102.19
Accounts Receivable
59.56
-19.69%
74.17
-27.92%
102.90
+23.35%
83.42
Gross Accounts Receivable
76.44
-17.62%
92.78
-25.34%
124.28
+19.97%
103.59
Allowance For Doubtful Accounts Receivable
-16.87
+9.36%
-18.62
+12.92%
-21.38
-5.99%
-20.17
Other Receivables
2.63
+101.69%
1.30
+93.75%
0.67
+37.42%
0.49
Inventory
58.22
-0.14%
58.30
+5.19%
55.42
+27.06%
43.62
Raw Materials
7.43
-24.72%
9.87
-9.52%
10.91
+20.71%
9.04
Work In Process
33.05
-1.55%
33.57
-0.95%
33.89
+25.45%
27.02
Finished Goods
17.74
+19.37%
14.86
+6.26%
13.98
+34.40%
10.40
Prepaid Assets
10.79
+246.88%
3.11
+27.83%
2.43
+42.53%
1.71
Current Deferred Assets
—
16.41
+31.76%
12.46
+11.76%
11.14
Restricted Cash
0.00
-99.98%
12.11
0.00
—
Total Non Current Assets
315.68
+1.62%
310.65
+1.73%
305.37
+8.93%
280.33
Net PPE
255.16
-3.07%
263.25
-4.35%
275.23
+11.69%
246.41
Gross PPE
366.72
+3.05%
355.85
+2.06%
348.65
+3.23%
337.73
Accumulated Depreciation
-111.55
-20.47%
-92.60
-26.12%
-73.42
+19.59%
-91.31
Properties
0.00
0.00
0.00
0.00
Land And Improvements
—
12.86
+0.00%
12.86
+0.00%
12.86
Buildings And Improvements
205.43
+4.17%
197.19
+64.62%
119.79
-28.23%
166.90
Machinery Furniture Equipment
3.28
+0.00%
3.28
-1.23%
3.32
+0.00%
3.32
Construction In Progress
9.75
+28.05%
7.62
-90.72%
82.06
+55.56%
52.76
Other Properties
148.26
+0.34%
147.76
+2.98%
143.48
+25.03%
114.75
Goodwill And Other Intangible Assets
22.78
-6.96%
24.48
-12.25%
27.90
+34.47%
20.75
Other Intangible Assets
22.78
-6.96%
24.48
-12.25%
27.90
+34.47%
20.75
Non Current Deferred Assets
19.04
+16.01%
16.41
—
—
Non Current Deferred Taxes Assets
10.99
-7.75%
11.91
—
—
Non Current Prepaid Assets
18.70
+187.48%
6.50
+191.14%
2.23
-83.04%
13.17
Total Liabilities Net Minority Interest
140.71
-12.40%
160.62
-1.35%
162.81
+28.76%
126.44
Current Liabilities
135.91
-9.54%
150.23
-1.31%
152.23
+21.17%
125.63
Payables And Accrued Expenses
47.31
-27.82%
65.55
-28.56%
91.75
+1.41%
90.47
Payables
47.21
-27.96%
65.54
-28.56%
91.74
+1.75%
90.16
Accounts Payable
42.96
-5.91%
45.66
-42.41%
79.28
+2.20%
77.57
Other Payable
2.04
+5.70%
1.93
-21.76%
2.47
+18.77%
2.08
Dividends Payable
0.00
-100.00%
15.65
0.00
-100.00%
3.71
Current Accrued Expenses
0.10
+890.00%
0.01
+0.00%
0.01
-96.77%
0.31
Total Tax Payable
2.07
-9.98%
2.29
-77.04%
10.00
+46.87%
6.81
Current Debt And Capital Lease Obligation
81.63
+2.22%
79.86
+45.49%
54.89
+82.97%
30.00
Current Debt
81.63
+2.22%
79.86
+45.49%
54.89
+82.97%
30.00
Other Current Borrowings
7.19
-91.00%
79.86
+45.49%
54.89
+82.97%
30.00
Current Deferred Liabilities
6.41
+60.75%
3.98
-15.23%
4.70
+9.73%
4.28
Current Deferred Revenue
3.69
-7.53%
3.98
-15.23%
4.70
+9.73%
4.28
Other Current Liabilities
0.56
-33.89%
0.84
-5.08%
0.89
+1.96%
0.87
Total Non Current Liabilities Net Minority Interest
4.80
-53.77%
10.38
-1.86%
10.58
+1196.57%
0.82
Long Term Debt And Capital Lease Obligation
4.80
-51.95%
9.99
+0.00%
9.99
—
Long Term Debt
4.80
-51.95%
9.99
+0.00%
9.99
—
Tradeand Other Payables Non Current
0.00
-100.00%
0.39
-33.39%
0.59
-27.70%
0.82
Stockholders Equity
283.96
+4.07%
272.85
-7.98%
296.50
+10.85%
267.47
Common Stock Equity
283.96
+4.07%
272.85
-7.98%
296.50
+10.85%
267.47
Capital Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Share Issued
47.17
+0.00%
47.17
+0.00%
47.17
+0.00%
47.17
Ordinary Shares Number
47.17
+0.00%
47.17
+0.00%
47.17
+0.00%
47.17
Additional Paid In Capital
203.15
+0.00%
203.15
+0.00%
203.15
+0.00%
203.15
Retained Earnings
48.15
+25.46%
38.38
-41.65%
65.77
+55.40%
42.33
Gains Losses Not Affecting Retained Earnings
32.65
+4.28%
31.31
+13.59%
27.57
+25.35%
21.99
Minority Interest
68.58
+3.25%
66.42
+10.02%
60.37
+17.54%
51.36
Other Equity Adjustments
32.65
+4.28%
31.31
+13.59%
27.57
+25.35%
21.99
Total Equity Gross Minority Interest
352.54
+3.91%
339.27
-4.93%
356.87
+11.93%
318.84
Total Capitalization
288.76
+2.09%
282.84
-7.72%
306.49
+14.59%
267.47
Working Capital
41.66
+6.80%
39.01
-37.17%
62.08
+57.89%
39.32
Invested Capital
370.39
+2.12%
362.70
+0.37%
361.38
+21.48%
297.47
Total Debt
86.43
-3.80%
89.85
+38.49%
64.88
+116.27%
30.00
Net Debt
67.83
-9.29%
74.78
+35.63%
55.13
+132.48%
23.72
Net Tangible Assets
261.18
+5.16%
248.37
-7.53%
268.59
+8.86%
246.72
Tangible Book Value
261.18
+5.16%
248.37
-7.53%
268.59
+8.86%
246.72
Current Deferred Taxes Assets
—
11.91
-4.34%
12.46
+11.76%
11.14
Duefrom Related Parties Current
0.74
+0.00%
0.74
0.00
—
Dueto Related Parties Current
0.15
0.00
—
—
Inventories Adjustments Allowances
—
-13.39
-298.42%
-3.36
-18.43%
-2.84
Line Of Credit
74.44
-6.78%
79.86
—
—
Notes Receivable
25.59
+10.24%
23.21
-24.33%
30.68
+67.85%
18.28
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
41.05
-14.81%
48.18
+177.96%
17.34
-45.50%
31.81
Cash Flow From Continuing Operating Activities
41.05
-14.81%
48.18
+177.96%
17.34
-45.50%
31.80
Net Income From Continuing Operations
13.47
-64.09%
37.51
-32.71%
55.74
+19.96%
46.47
Depreciation Amortization Depletion
24.16
+1.05%
23.91
+27.19%
18.80
+17.41%
16.01
Depreciation And Amortization
24.16
+1.05%
23.91
+27.19%
18.80
+17.41%
16.01
Other Non Cash Items
—
—
—
0.00
Provisionand Write Offof Assets
-1.78
+52.02%
-3.71
-138.15%
9.73
+405.71%
1.93
Asset Impairment Charge
5.96
-40.53%
10.03
+935.74%
0.97
-36.36%
1.52
Deferred Tax
0.92
+70.79%
0.54
+141.27%
-1.31
-266.20%
-0.36
Deferred Income Tax
0.92
+70.79%
0.54
+141.27%
-1.31
-266.20%
-0.36
Operating Gains Losses
-0.51
-370.05%
0.19
—
-0.05
Unrealized Gain Loss On Investment Securities
-0.21
0.00
0.00
—
Net Foreign Currency Exchange Gain Loss
-0.68
0.00
0.00
—
Gain Loss On Sale Of PPE
0.17
-6.95%
0.19
0.00
+100.00%
-0.05
Change In Working Capital
-0.98
+95.18%
-20.28
+69.55%
-66.60
-97.57%
-33.71
Change In Receivables
12.59
-67.39%
38.62
+181.51%
-47.37
-16.45%
-40.68
Changes In Account Receivables
16.34
-47.35%
31.04
+225.56%
-24.72
+13.26%
-28.50
Change In Inventory
-5.88
+54.41%
-12.90
-4.68%
-12.32
+0.15%
-12.34
Change In Prepaid Assets
-8.96
-658.04%
-1.18
-64.85%
-0.72
-48.76%
-0.48
Change In Payables And Accrued Expense
1.67
+103.79%
-44.09
-578.37%
-6.50
-134.89%
18.63
Change In Accrued Expense
2.70
+563.57%
-0.58
-381.16%
0.21
-60.27%
0.52
Change In Payable
-1.03
+97.64%
-43.51
-548.76%
-6.71
-137.03%
18.11
Change In Account Payable
-0.40
+98.87%
-35.61
-268.17%
-9.67
-154.86%
17.63
Change In Other Working Capital
-0.40
+44.06%
-0.71
-325.55%
0.32
-77.29%
1.40
Change In Other Current Liabilities
—
-0.22
-6.86%
-0.20
+11.30%
-0.23
Investing Cash Flow
-27.66
-135.15%
-11.77
+56.95%
-27.33
-4.03%
-26.27
Cash Flow From Continuing Investing Activities
-27.66
-135.15%
-11.77
+56.95%
-27.33
-4.03%
-26.27
Net PPE Purchase And Sale
-13.48
-112.70%
-6.34
+76.81%
-27.33
-44.35%
-18.93
Purchase Of PPE
-13.59
-83.71%
-7.40
+72.94%
-27.33
-43.38%
-19.06
Sale Of PPE
0.11
-89.80%
1.06
0.00
-100.00%
0.13
Capital Expenditure
-27.77
-139.42%
-11.60
+57.55%
-27.33
-3.52%
-26.40
Net Investment Purchase And Sale
0.00
+100.00%
-1.22
0.00
—
Purchase Of Investment
0.00
+100.00%
-1.22
0.00
—
Net Intangibles Purchase And Sale
-14.19
-237.44%
-4.20
0.00
+100.00%
-7.34
Purchase Of Intangibles
-14.19
-237.44%
-4.20
0.00
+100.00%
-7.34
Financing Cash Flow
-22.13
-16.60%
-18.98
-241.06%
13.46
+541.44%
-3.05
Cash Flow From Continuing Financing Activities
-22.13
-16.60%
-18.98
-241.06%
13.46
+541.44%
-3.05
Net Issuance Payments Of Debt
-2.74
-110.97%
24.97
-28.41%
34.88
+336.00%
8.00
Issuance Of Debt
90.12
+12.85%
79.86
-20.02%
99.85
+232.84%
30.00
Repayment Of Debt
-92.86
-69.17%
-54.89
+15.52%
-64.97
-195.33%
-22.00
Long Term Debt Issuance
90.12
+12.85%
79.86
-20.02%
99.85
+232.84%
30.00
Long Term Debt Payments
-92.86
-69.17%
-54.89
+15.52%
-64.97
-195.33%
-22.00
Net Long Term Debt Issuance
-2.74
-110.97%
24.97
-28.41%
34.88
+336.00%
8.00
Common Stock Dividend Paid
-16.02
+59.39%
-39.45
-84.14%
-21.43
-93.93%
-11.05
Cash Dividends Paid
-16.02
+59.39%
-39.45
-84.14%
-21.43
-93.93%
-11.05
Net Other Financing Charges
-3.37
+25.11%
-4.50
—
—
Changes In Cash
-8.75
-150.16%
17.44
+403.76%
3.46
+39.09%
2.49
Effect Of Exchange Rate Changes
0.17
0.00
0.00
—
Beginning Cash Position
27.19
+178.95%
9.75
+55.09%
6.28
+65.59%
3.79
End Cash Position
18.61
-31.56%
27.19
+178.95%
9.75
+55.09%
6.28
Free Cash Flow
13.27
-63.72%
36.58
+466.10%
-9.99
-284.75%
5.41
Interest Paid Supplemental Data
3.98
-9.90%
4.42
+55.79%
2.84
+171.41%
1.05
Income Tax Paid Supplemental Data
0.12
-98.89%
10.49
+23.64%
8.48
+21.42%
6.99
Change In Income Tax Payable
-0.23
+97.03%
-7.70
-341.37%
3.19
+298.38%
0.80
Change In Tax Payable
-0.23
+97.03%
-7.70
-341.37%
3.19
+298.38%
0.80
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category